Stock vs Stock Comparison

Emerson Electric Co. vs American Battery Technology Company

EMR wins the Tale of the Tape 7–2.

EMR$142.03
ABAT

🏆 Tale of the Tape

72
EMRABAT
12.7%Profitability (Net Margin)-1090.0%
33.4xValuation (P/E)
8.2%Efficiency (ROIC)-52.2%
7/9Health (Piotroski F)5/9
4.2Safety (Altman Z)
3.0%Growth (Rev YoY)1149.0%
1.16Risk (Sharpe 1Y)
1.07xBalance Sheet (D/E)0.20x
3.04%FCF Yield

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricEMRABAT
Market Cap$80.6B
P/E Ratio33.4x
Forward P/E20.1x
P/B3.97x
Dividend Yield1.54%
Beta1.25

Quantitative Metrics

MetricEMRABAT
DCF Fair Value$69.37
DCF Upside-52.0%
Piotroski F7/95/9
Altman Z4.25
Beneish M-2.635.95
FCF Yield3.04%
Net Debt/EBITDA1.4x
ROIC8.2%-52.2%
WACC11.8%
ROIC – WACC-3.7pp
Gross Margin52.8%-246.5%
Net Margin12.7%-1090.0%
Rev Growth YoY3.0%1149.0%
Sharpe (1Y)1.16
Max Drawdown 3Y
FCF Payout Ratio45%

EMR Price

Loading chart...

ABAT Price

Loading chart...

ETF Exposure

EMR found in:

XLI1.43%
NOBL1.40%
VIS1.12%
SDY0.67%
MGV0.39%
VIG0.36%
VYM0.33%
VTV0.31%
SCHV0.29%
SPYV0.26%
IWD0.24%
VONV0.24%
RSP0.21%
SCHX0.14%
SPLG0.13%
VOO0.13%
IVV0.13%
SCHB0.13%
GWX0.12%
VONE0.12%
SPY0.12%
ITOT0.11%
VTI0.11%
SPTM0.11%
ONEO0.11%
URTH0.10%
ACWI0.09%
VT0.07%
VSS0.05%
QUS0.05%

ABAT found in:

XME0.50%
VFMO0.09%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

EMR vs ABAT: Head-to-Head Analysis

Emerson Electric Co. (EMR) and American Battery Technology Company (ABAT) represent two companies in the Industrials sector. In our quantitative Tale of the Tape scoring, EMR leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, EMR generates a return on invested capital (ROIC) of 8.2% compared to ABAT's -52.2%. This suggests EMR is more effective at deploying capital to generate shareholder returns.

EMR appears in 30 ETFs tracked by SecuritiesDB, while ABAT appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, EMR or ABAT?

Our quantitative analysis compares EMR and ABAT across nine fundamental dimensions. EMR wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are EMR and ABAT correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.